Shanghai INT Medical Instruments Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003NH7
  • HKG: 1501
HKD
34.88
9.88 (39.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore

Dashboard

1

High Debt company with Weak Long Term Fundamental Strength

  • The company is Net-Debt Free
2

Flat results in Jun 26

3

With ROE of 10.44%, it has a Fair valuation with a 2.99 Price to Book Value

4

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

HKD 7,231 Million ()

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.54%

stock-summary
Debt Equity

-0.23

stock-summary
Return on Equity

8.63%

stock-summary
Price to Book

2.27

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
28.71%
0%
28.71%
6 Months
27.77%
0%
27.77%
1 Year
28.0%
0%
28.0%
2 Years
24.57%
0%
24.57%
3 Years
99.31%
0%
99.31%
4 Years
-16.95%
0%
-16.95%
5 Years
-44.01%
0%
-44.01%

Shanghai INT Medical Instruments Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
23.47%
EBIT Growth (5y)
13.65%
EBIT to Interest (avg)
64.91
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.18
Sales to Capital Employed (avg)
0.40
Tax Ratio
9.43%
Dividend Payout Ratio
19.09%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.86%
ROE (avg)
9.07%

Valuation key factors

Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
2.99
EV to EBIT
27.92
EV to EBITDA
18.97
EV to Capital Employed
2.94
EV to Sales
5.79
PEG Ratio
3.46
Dividend Yield
0.59%
ROCE (Latest)
10.54%
ROE (Latest)
10.44%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Shanghai INT Medical Instruments Co., Ltd."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 25.09% vs 11.03% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 15.82% vs 21.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,155.50",
          "val2": "923.70",
          "chgp": "25.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "352.60",
          "val2": "291.40",
          "chgp": "21.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "13.60",
          "val2": "2.60",
          "chgp": "423.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.50",
          "val2": "-9.40",
          "chgp": "179.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "238.70",
          "val2": "206.10",
          "chgp": "15.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "207.30%",
          "val2": "221.80%",
          "chgp": "-1.45%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
1,155.50
923.70
25.09%
Operating Profit (PBDIT) excl Other Income
352.60
291.40
21.00%
Interest
13.60
2.60
423.08%
Exceptional Items
7.50
-9.40
179.79%
Consolidate Net Profit
238.70
206.10
15.82%
Operating Profit Margin (Excl OI)
207.30%
221.80%
-1.45%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 25.09% vs 11.03% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 15.82% vs 21.74% in Dec 2024

stock-summaryCompany CV
About Shanghai INT Medical Instruments Co., Ltd. stock-summary
stock-summary
Shanghai INT Medical Instruments Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Footer loading